Fatty Acid β-Oxidation-Dependent Bioactivation of 5,6-Dichloro-4-Thia-5-Hexenoate and Analogs in Isolated Rat Hepatocytes

  • M. E. Fitzsimmons
  • M. W. Anders
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 283)


S-(1,2-Dichlorovinyl)-L-cysteine (DCVC) is a nephrotoxic agent found in trichloroethene-extracted soybean meal (McKinney et al., 1957). Structure-toxicity studies with DCVC showed that the decarboxylated analog S-(1,2-dichlorovinyl)cysteamine was nontoxic whereas the desamino analog 5,6-dichloro-4-thia-5-hexenoate (DCTH) was a potent inhibitor of mitochondrial respiration (Parker et al., 1965; Stonard et al., 1977). The bioactivation mechanism of DCVC has been elucidated (Anders et al., 1988), but the bioactivation mechanism of DCTH has, however, not been defined. The objective of the present study was to elucidate the bioactivation mechanism of DCTH. This research tested the hypothesis that DCTH is bioactivated by enzymes of the fatty acid β-oxidation pathway to cytotoxic intermediates (Fig. 1). Specifically, DCTH may be metabolized by fatty acid acylCoA synthetase to the corresponding CoA thioester 1, which may be metabolized by fatty acid acyl-CoA dehydrogenase to 5,6-dichloro-4-thia-2,5-hexadienoate 2. Dienoate 2 may be metabolized by enoyl-CoA hydratase to the hemimercaptal 5,6-dichloro-4-thia-3-hydroxy-5-hexenoate 3, which may eliminate the unstable enethiol 1,2-dichloroethenethiol 4 whose formation is associated with the toxicity of DCVC (Anders et al., 1988).


Octanoic Acid Sodium Benzoate Mercaptopropionic Acid Nephrotoxic Agent Cytotoxic Metabolite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anders, M. W., Lash, L. H., Dekant, W., Elfarra, A. A., and Dohn, D. R. (1988). Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. CRC Crit. Rev. Toxicol. 18, 311–341.CrossRefGoogle Scholar
  2. McKinney, L. L., Weakley, F. B., Eldridge, A. C., Campbell, R. E., Cowan, J. C., Picken, J. C., and Biester, H. E. (1978). S-(Dichlorovinyl)-L-cysteine: An agent causing fatal aplastic anemia in calves. J. Am. Chem. Soc. 79, 3932–3933.CrossRefGoogle Scholar
  3. Moldéus, P., Högberg, J., and Orrenius, S. (1978). Isolation and use of liver cells. Methods Enzymol. 52, 60–70.CrossRefPubMedGoogle Scholar
  4. Parker, V. H. (1965). A biochemical study of the toxicity of S- dichlorovinyl-Lcysteine. Fd. Cosmet. Toxicol. 3, 75–84.CrossRefGoogle Scholar
  5. Stonard, M. D., and Parker, V. H. (1971). 2-Oxoacid dehydrogenases of rat liver mitochondria as the site of action of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2dichlorovinyl)-3-mercaptopropionic acid. Biochem. Pharmacol. 20, 2417–2427.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • M. E. Fitzsimmons
    • 1
  • M. W. Anders
    • 1
  1. 1.Department of PharmacologyUniversity of RochesterRochesterUSA

Personalised recommendations